Patent · US Active

Engineered nucleic acids and methods of use thereof

US9464124B2 · kind B2 · utility

159Cited by

383References

17Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Stephane Bancel · Cambridge, US
Jason P. Schrum · Philadelphia, US
Alexander Aristarkhov · Sharon, US

Key dates

Filing date	Nov 5, 2014
Grant date	Oct 11, 2016
Priority date	—
Expiry date	Nov 5, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y301/27
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are compositions and methods for delivering biological moieties such as modified nucleic acids into cells to kill or reduce the growth of microorganisms. Such compositions and methods include the use of modified messenger RNAs, and are useful to treat or prevent microbial infection, or to improve a subject's heath or wellbeing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.